{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:09:23Z","timestamp":1791119363196,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1150,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[1998,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The objective of the present study was to investigate the relationship between the serum cytokine pattern of T\u2010helper (Th) response and the acquisition of syncytium\u2010inducing (SI) human immunodeficiency virus type 1 (HIV\u20101) variants in HIV\u20101\u2010seropositive patients treated with antiretroviral drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum cytokines of Th1\/Th2 responses were analysed in a case\u2013control study of 20 individuals selected from a cohort of HIV\u20101\u2010infected patients without SI variants at entry, who developed or did not develop SI virus during a prospective follow\u2010up. A group of 10 patients with SI variants at study entry was also evaluated. Serum concentration of interferon (IFN) gamma, interleukin (IL) 2, IL\u20104 and IL\u201010 was evaluated by mean of a commercial enzyme immunoassay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Despite close matching for immunological (CD4<jats:sup>+<\/jats:sup> cell count) and virological (p24 antigen, serum HIV viraemia) parameters, SI\u2010converting patients showed at baseline significantly lower serum levels of IL\u20102 and higher concentrations of IL\u20104 than those who remained persistently negative for SI variants. Shortly after the phenotype conversion, SI\u2010converting patients were characterized by significantly high serum concentration of IL\u20104 and by low levels of IFN\u2010\u03b3 (Th2\u2010like pattern). Patients with SI phenotype at study entry featured lower mean levels of both IL\u20104 and IL\u201010, but mean IFN\u2010\u03b3 and IL\u20102 values were higher, although the clinical and immunological baseline was also poorer and no statistical analysis could be applied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Serum cytokine pattern of Th1\/Th2 response differs between patients with NSI and SI phenotype. Our data strongly suggest that the Th2 cytokine pattern could be associated with the acquisition of the SI HIV\u20101 phenotype.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2362.1998.00368.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T15:41:02Z","timestamp":1047397262000},"page":"930-936","source":"Crossref","is-referenced-by-count":13,"title":["Evidence for a role of T\u2010helper type 2 cytokines in the acquisition of human immunodeficiency virus syncytium\u2010inducing phenotype"],"prefix":"10.1111","volume":"28","author":[{"family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"S\u00e1nchez\u2010Quijano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Lissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.1998.00368.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.1998.00368.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2362.1998.00368.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T01:28:33Z","timestamp":1698456513000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2362.1998.00368.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["10.1046\/j.1365-2362.1998.00368.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2362.1998.00368.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}